Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
Liesbeth C.W. Vredeveld, Patrícia A. Possik, Marjon A. Smit, et al.
Genes & Development (2012) Vol. 26, Iss. 10, pp. 1055-1069
Open Access | Times Cited: 253

Showing 1-25 of 253 citing articles:

The role of senescent cells in ageing
Jan M. van Deursen
Nature (2014) Vol. 509, Iss. 7501, pp. 439-446
Open Access | Times Cited: 2288
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Weiyi Peng, Jie Qing Chen, Chengwen Liu, et al.
Cancer Discovery (2015) Vol. 6, Iss. 2, pp. 202-216
Open Access | Times Cited: 1335
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer, Yong Kong, Byung Hak Ha, et al.
Nature Genetics (2012) Vol. 44, Iss. 9, pp. 1006-1014
Open Access | Times Cited: 1130
Forging a signature of in vivo senescence
Norman E. Sharpless, Charles J. Sherr
Nature reviews. Cancer (2015) Vol. 15, Iss. 7, pp. 397-408
Closed Access | Times Cited: 941
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Joanna Kaplon, Liang Zheng, Katrin Meissl, et al.
Nature (2013) Vol. 498, Iss. 7452, pp. 109-112
Closed Access | Times Cited: 585
Senescence-associated inflammatory responses: aging and cancer perspectives
Audrey Lasry, Yinon Ben‐Neriah
Trends in Immunology (2015) Vol. 36, Iss. 4, pp. 217-228
Closed Access | Times Cited: 384
Senescent cells harbour features of the cancer epigenome
Hazel A. Cruickshanks, Tony McBryan, David M. Nelson, et al.
Nature Cell Biology (2013) Vol. 15, Iss. 12, pp. 1495-1506
Open Access | Times Cited: 336
The dynamic control of signal transduction networks in cancer cells
Walter Kölch, Melinda Halász, Marina Granovskaya, et al.
Nature reviews. Cancer (2015) Vol. 15, Iss. 9, pp. 515-527
Closed Access | Times Cited: 324
RAF-MEK-ERK pathway in cancer evolution and treatment
Rahim Ullah, Qing Yin, Aidan Snell, et al.
Seminars in Cancer Biology (2021) Vol. 85, pp. 123-154
Closed Access | Times Cited: 287
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
Daixi Ren, Yuze Hua, Boyao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 249
The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma
Karen E. Sheppard, Grant A. McArthur
Clinical Cancer Research (2013) Vol. 19, Iss. 19, pp. 5320-5328
Closed Access | Times Cited: 239
Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence
Yingxi Xu, Na Li, Rong Xiang, et al.
Trends in Biochemical Sciences (2014) Vol. 39, Iss. 6, pp. 268-276
Open Access | Times Cited: 234
Elucidating Distinct Roles for NF1 in Melanomagenesis
Ophélia Maertens, Bryan W. Johnson, Pablo E. Hollstein, et al.
Cancer Discovery (2012) Vol. 3, Iss. 3, pp. 338-349
Open Access | Times Cited: 227
Melanocytic nevi and melanoma: unraveling a complex relationship
William Damsky, Marcus Bosenberg
Oncogene (2017) Vol. 36, Iss. 42, pp. 5771-5792
Open Access | Times Cited: 217
Pathways and therapeutic targets in melanoma
Emma Shtivelman, Michael A. Davies, Patrick Hwu, et al.
Oncotarget (2014) Vol. 5, Iss. 7, pp. 1701-1752
Open Access | Times Cited: 205
Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma
Xiaoqi Xie, Ju Yong Koh, Sandy M. Price, et al.
Cancer Discovery (2015) Vol. 5, Iss. 4, pp. 410-423
Open Access | Times Cited: 194
Focus on the Contribution of Oxidative Stress in Skin Aging
Federica Papaccio, Andrea D’Arino, Silvia Caputo, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1121-1121
Open Access | Times Cited: 166
Melanoma models for the next generation of therapies
E. Elizabeth Patton, Kristen L. Mueller, David J. Adams, et al.
Cancer Cell (2021) Vol. 39, Iss. 5, pp. 610-631
Open Access | Times Cited: 158
Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells
Stephanie Arndt, Eva Wacker, Yang‐Fang Li, et al.
Experimental Dermatology (2013) Vol. 22, Iss. 4, pp. 284-289
Closed Access | Times Cited: 198
Genetics of melanocytic nevi
Mi Ryung Roh, Philip Eliades, Sameer Gupta, et al.
Pigment Cell & Melanoma Research (2015) Vol. 28, Iss. 6, pp. 661-672
Open Access | Times Cited: 166
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
Xiangjun Kong, Thomas Kuilman, Aida Shahrabi, et al.
Nature (2017) Vol. 550, Iss. 7675, pp. 270-274
Open Access | Times Cited: 145
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma
Yong Yu, Kolja Schleich, Bin Yue, et al.
Cancer Cell (2018) Vol. 33, Iss. 2, pp. 322-336.e8
Open Access | Times Cited: 144
Dabrafenib and its potential for the treatment of metastatic melanoma
Rajmohan Murali, Alexander M. Menzies, Georgina V. Long
Drug Design Development and Therapy (2012), pp. 391-391
Open Access | Times Cited: 143
MC1R Is a Potent Regulator of PTEN after UV Exposure in Melanocytes
Juxiang Cao, Lixin Wan, Elke Hacker, et al.
Molecular Cell (2013) Vol. 51, Iss. 4, pp. 409-422
Open Access | Times Cited: 139
The Conundrum of Genetic “Drivers” in Benign Conditions
Shumei Kato, Scott M. Lippman, Keith T. Flaherty, et al.
JNCI Journal of the National Cancer Institute (2016) Vol. 108, Iss. 8, pp. djw036-djw036
Open Access | Times Cited: 136
Page 1 - Next Page

Scroll to top